Mn Services Vermogensbeheer B.V. Alkermes Plc. Transaction History

Mn Services Vermogensbeheer B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$19.51 - $24.28 $514,088 - $639,778	-26,350 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $69,850 - $111,525	2,500 Added 10.48%	26,350 $680,000
Q4 2017 Feb 02, 2018	SELL	$47.69 - $55.39 $42,921 - $49,851	-900 Reduced 3.64%	23,850 $1.09 Million
Q3 2017 Nov 01, 2017	BUY	$49.16 - $54.45 $1.22 Million - $1.35 Million	24,750	24,750 $1.26 Million

375

166M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.51B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.